These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32193888)

  • 21. Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma.
    Kim S; Shin J; Kim DY; Choi GH; Kim MJ; Choi JY
    Clin Cancer Res; 2019 Jul; 25(13):3847-3855. PubMed ID: 30808773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-operative ADC predicts early recurrence of HCC after curative resection.
    Lee S; Kim SH; Hwang JA; Lee JE; Ha SY
    Eur Radiol; 2019 Feb; 29(2):1003-1012. PubMed ID: 30027408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IVIM improves preoperative assessment of microvascular invasion in HCC.
    Wei Y; Huang Z; Tang H; Deng L; Yuan Y; Li J; Wu D; Wei X; Song B
    Eur Radiol; 2019 Oct; 29(10):5403-5414. PubMed ID: 30877465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma: A STROBE-compliant article.
    Shin SK; Kim YS; Shim YS; Choi SJ; Park SH; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Aug; 96(33):e7761. PubMed ID: 28816953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
    Wang J; Shan Q; Liu Y; Yang H; Kuang S; He B; Zhang Y; Chen J; Zhang T; Glaser KJ; Zhu C; Chen J; Yin M; Venkatesh SK; Ehman RL
    J Magn Reson Imaging; 2019 Mar; 49(3):719-730. PubMed ID: 30260529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation.
    Lee S; Kang TW; Song KD; Lee MW; Rhim H; Lim HK; Kim SY; Sinn DH; Kim JM; Kim K; Ha SY
    Ann Surg; 2021 Mar; 273(3):564-571. PubMed ID: 31058694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T
    Wang WT; Zhu S; Ding Y; Yang L; Chen CZ; Ye QH; Ji Y; Zeng MS; Rao SX
    Eur J Radiol; 2018 Jun; 103():25-31. PubMed ID: 29803381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
    Huang K; Dong Z; Cai H; Huang M; Peng Z; Xu L; Jia Y; Song C; Li ZP; Feng ST
    BMC Cancer; 2019 Apr; 19(1):364. PubMed ID: 30999947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-to-Lymphocyte Ratio and Large Tumor Size Predict Microvascular Invasion after Resection for Hepatocellular Carcinoma.
    Rungsakulkij N; Mingphruedhi S; Suragul W; Tangtawee P; Muangkaew P; Aeesoa S
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3435-3441. PubMed ID: 30583666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
    Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
    Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
    World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Jin YJ; Lee SH; Cho SG; Kim JH; Lee JW; Lee KY; Shin WY
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1349-56. PubMed ID: 26916616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion.
    Tsujita Y; Sofue K; Komatsu S; Yamaguchi T; Ueshima E; Ueno Y; Kanda T; Okada T; Nogami M; Yamaguchi M; Tsurusaki M; Hori M; Fukumoto T; Murakami T
    Eur J Radiol; 2020 Sep; 130():109189. PubMed ID: 32784077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
    Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
    World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.
    Han S; Lee S; Yang JD; Leise MD; Ahn JH; Kim S; Jung K; Gwak MS; Kim GS; Ko JS
    Liver Transpl; 2018 Jan; 24(1):44-55. PubMed ID: 29024412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.